Sign in

CIK 0001479419 · Non-accelerated filer<br>Smaller reporting company

KALA BIO, Inc.

Sign in to watch
Ticker
KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
270604595
Phone
781-996-5252
Business address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Former names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-06-15 Iwicki Mark T Director Grant or award +2,450 271,660
2025-06-15 Iwicki Mark T Director Grant or award · Stock Option (right to buy) +5,450 5,450
2025-06-15 Farid Marjan Director Grant or award +2,450 10,242
2025-06-15 Farid Marjan Director Grant or award · Stock Option (right to buy) +5,450 5,450
2025-06-15 PERRY GREGORY D Director Grant or award +2,450 13,344
2025-06-15 PERRY GREGORY D Director Grant or award · Stock Option (right to buy) +5,450 5,450
2025-06-15 Myers C. Daniel Director Grant or award +2,450 10,374
2025-06-15 Myers C. Daniel Director Grant or award · Stock Option (right to buy) +5,450 5,450
2025-06-15 KOVEN ANDREW I Director Grant or award +3,050 16,972
2025-06-15 KOVEN ANDREW I Director Grant or award · Stock Option (right to buy) +6,850 6,850
2025-06-03 Iwicki Mark T Director Sale −10,866 $3.74 $41K 269,210
2025-06-03 Kharabi Darius CHIEF BUSINESS OFFICER Sale −730 $3.74 $3K 67,077
2025-06-03 Reumuth Mary CHIEF FINANCIAL OFFICER Sale −2,850 $3.74 $11K 65,731
2025-06-03 Bazemore Todd SEE REMARKS Sale −3,390 $3.74 $13K 87,757
2025-06-03 Brazzell Romulus K SEE REMARKS Sale −3,687 $3.74 $14K 87,949
2025-06-03 Iwicki Mark T Director Sale +10,866 $3.74 $41K 269,210
2025-03-07 Bazemore Todd SEE REMARKS Grant or award · Stock Option (right to buy) +45,200 45,200
2025-01-06 Kharabi Darius CHIEF BUSINESS OFFICER Grant or award +10,100 69,828
2025-01-06 Kharabi Darius CHIEF BUSINESS OFFICER Sale −2,021 $7.63 $15K 67,807
2025-01-06 Kharabi Darius CHIEF BUSINESS OFFICER Grant or award · Stock Option (right to buy) +45,200 45,200

Page 2 of 12 · 236 trades